Graham Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,857
Closed -$502K 1408
2025
Q4
$502K Buy
38,857
+28,762
+285% +$369K 0.01% 626
2025
Q3
$130K Sell
10,095
-17,950
-64% -$240K ﹤0.01% 1135
2025
Q2
$499K Sell
28,045
-23,746
-46% -$414K 0.01% 821
2025
Q1
$923K Buy
51,791
+30,082
+139% +$683K 0.02% 578
2024
Q4
$647K Sell
21,709
-31,236
-59% -$661K 0.01% 655
2024
Q3
$828K Buy
+52,945
New +$960K 0.01% 507
2024
Q2
Sell
-18,716
Closed -$293K 1268
2024
Q1
$293K Sell
18,716
-45,190
-71% -$665K 0.01% 795
2023
Q4
$954K Buy
+63,906
New +$855K 0.02% 403
2023
Q3
Sell
-17,726
Closed -$736K 1208
2023
Q2
$736K Buy
17,726
+13,540
+323% +$841K 0.02% 446
2023
Q1
$252K Buy
+4,186
New +$335K 0.01% 913
2022
Q3
Sell
-12,339
Closed -$857K 1229
2022
Q2
$857K Buy
+12,339
New +$929K 0.03% 489

Other funds holding NVCR